Gap between FDA-approved drugs and wellness peptides is wide Peptides are the building blocks of more complex proteins, triggering hormones inside the body needed for growth, metabolism and healing
Figure 1: Changes in gross morphological scores amongst the four experimental treatment groups
Association between cognitive impairment and malnutrition in hemodialysis patients: two sides of the same coin
Ipamorelin has been the subject of peer-reviewed research since its initial characterisation in 1998, with studies spanning neuroendocrinology, bone biology, body composition, and pharmacokinetics
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial